Literature DB >> 22343810

Personalized medicine: a personal view.

U A Meyer1.   

Abstract

Personalized medicine is a strategy to prevent, diagnose, and treat disease so as to achieve an optimal result for the individual. The sequencing of the human genome and other technological advances have revealed the extent of genetic diversity and the relative contribution of genetic and nongenetic factors to human health, disease, and drug response. The challenge is to translate this knowledge into tangible benefits for the patient.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22343810     DOI： 10.1038/clpt.2011.238

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


  8 in total

Review 1.  Dawn of ocular gene therapy: implications for molecular diagnosis in retinal disease.

Authors:  Jacques Zaneveld; Feng Wang; Xia Wang; Rui Chen
Journal:  Sci China Life Sci       Date:  2013-02-08       Impact factor: 6.038

2.  Patient-centered medicine and patient-oriented research: improving health outcomes for individual patients.

Authors:  José A Sacristán
Journal:  BMC Med Inform Decis Mak       Date:  2013-01-08       Impact factor: 2.796

3.  Sequencing and analysis of a South Asian-Indian personal genome.

Authors:  Ravi Gupta; Aakrosh Ratan; Changanamkandath Rajesh; Rong Chen; Hie Lim Kim; Richard Burhans; Webb Miller; Sam Santhosh; Ramana V Davuluri; Atul J Butte; Stephan C Schuster; Somasekar Seshagiri; George Thomas
Journal:  BMC Genomics       Date:  2012-08-31       Impact factor: 3.969

4.  Personalized nanomedicine: future medicine for cancer treatment.

Authors:  Farooq A Shiekh
Journal:  Int J Nanomedicine       Date:  2013-01-09

5.  Improvement in vision: a new goal for treatment of hereditary retinal degenerations.

Authors:  Samuel G Jacobson; Artur V Cideciyan; Gustavo D Aguirre; Alejandro J Roman; Alexander Sumaroka; William W Hauswirth; Krzysztof Palczewski
Journal:  Expert Opin Orphan Drugs       Date:  2015-05-04       Impact factor: 0.694

Review 6.  Personalizing health care: feasibility and future implications.

Authors:  Brian Godman; Alexander E Finlayson; Parneet K Cheema; Eva Zebedin-Brandl; Inaki Gutiérrez-Ibarluzea; Jan Jones; Rickard E Malmström; Elina Asola; Christoph Baumgärtel; Marion Bennie; Iain Bishop; Anna Bucsics; Stephen Campbell; Eduardo Diogene; Alessandra Ferrario; Jurij Fürst; Kristina Garuoliene; Miguel Gomes; Katharine Harris; Alan Haycox; Harald Herholz; Krystyna Hviding; Saira Jan; Marija Kalaba; Christina Kvalheim; Ott Laius; Sven-Ake Lööv; Kamila Malinowska; Andrew Martin; Laura McCullagh; Fredrik Nilsson; Ken Paterson; Ulrich Schwabe; Gisbert Selke; Catherine Sermet; Steven Simoens; Dominik Tomek; Vera Vlahovic-Palcevski; Luka Voncina; Magdalena Wladysiuk; Menno van Woerkom; Durhane Wong-Rieger; Corrine Zara; Raghib Ali; Lars L Gustafsson
Journal:  BMC Med       Date:  2013-08-13       Impact factor: 8.775

7.  Biobanking from the patient perspective.

Authors:  Derick Mitchell; Jan Geissler; Alison Parry-Jones; Hans Keulen; Doris C Schmitt; Rosaria Vavassori; Balwir Matharoo-Ball
Journal:  Res Involv Engagem       Date:  2015-06-25

Review 8.  Idiopathic Pulmonary Fibrosis (IPF): An Overview.

Authors:  Shaney L Barratt; Andrew Creamer; Conal Hayton; Nazia Chaudhuri
Journal:  J Clin Med       Date:  2018-08-06       Impact factor: 4.241
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.